Ovid Therapeutics Inc. (NASDAQ:OVID) Receives Average Rating of “Buy” from Brokerages
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. […]
